×
ADVERTISEMENT

lymphoma

Supportive Care and Other Tools for Managing Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

In patients who received prior chronic lymphocytic leukemia/small lymphocytic lymphoma-directed therapy but require ...

MARCH 10, 2025

Key Treatment Principles and Recent Updates In the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic lymphocytic leukemia is a lymphoproliferative disorder characterized by the accumulation of circulating ...

APRIL 10, 2024

Cases of Rare, Fatal Cancer Linked to Celiac Disease Increasing

The incidence of enteropathy-associated T-cell lymphoma—a rare and aggressive T-cell, non-Hodgkin ...

MARCH 18, 2024

FDA Requires Boxed Warning of Secondary Malignancies for CAR-T Therapies

The FDA has called for a classwide boxed warning on all commercial CAR T-cell therapies after an investigation into ...

FEBRUARY 15, 2024

Study Finds Lower Risk for Hematologic Cancer After Bariatric Surgery in Women

Bariatric surgery is associated with a reduced incidence of hematologic cancer, specifically in women, according to ...

OCTOBER 23, 2023

Telehealth AYA Cancer Program Helps Identify Needed Resources

When oncologists with the University of Wisconsin Carbone Cancer Center, in Madison, wanted to start a dedicated ...

MAY 25, 2022

Large Study Suggests Possible New Standard for Previously Treated DLBCL

A new drug regimen containing the antibody-drug conjugate polatuzumab vedotin-piiq is challenging the previous ...

FEBRUARY 11, 2022

New CAR-T Data, Other Lymphoma Therapy Insights from ASH

In advanced forms of lymphoma, an avalanche of new data with chimeric antigen receptor T cells was presented at the ...

JANUARY 27, 2022

Xpovio Approved to Treat Relapsed or Refractory DLBCL

The FDA granted accelerated approval to selinexor (Xpovio, Karyopharm) for the treatment of adult patients with ...

JUNE 23, 2020

Novel Agent Found Effective in B-Cell Cancers, Even After CAR T-Cell Failure

A novel investigational bispecific antibody therapy called mosunetuzumab produced durable complete response sin ...

FEBRUARY 24, 2020

Link Found Between BRCA2 Gene and Pediatric Lymphoma

Younger survivors of non-Hodgkin lymphoma are five times more likely than similar-aged children who did not have ...

SEPTEMBER 24, 2019

Combo Thiopurine/Anti-TNF Treatment Boosts Lymphoma Risk

People with inflammatory bowel disease who receive combination treatment with thiopurines and anti–tumor ...

AUGUST 18, 2017

Load more